Elastin peptide analogs and uses thereof

Details Elastin peptide analogs and uses thereof Elastin peptide analogs and uses thereof

2005-11-08

2005-11-08

Borin, Michael (Department: 1631)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S017400, C514S018700, C530S328000, C530S329000, C530S330000

Reexamination Certificate

active

06962904

ABSTRACT:
The present invention is directed to a composition which is used to enhance the elasticity and/or appearance of tissue. Specifically, the present invention is directed to a composition formulated from peptides or peptide-like compounds having low molecular weights and which substantially correspond to sequences found in elastin. The present composition specifically includes chemical modification of the peptides described herein, specifically carboxy and amino modification including the addition of amino acids to either end of the peptide fragments.

REFERENCES:
patent: 4118480 (1978-10-01), Williams
patent: 4323553 (1982-04-01), Bouillon et al.
patent: 4327078 (1982-04-01), Charlet et al.
patent: 4381294 (1983-04-01), Bouillon et al.
patent: 4474763 (1984-10-01), Lubowe
patent: 4591501 (1986-05-01), Cioca
patent: 4603146 (1986-07-01), Kligman
patent: 4659740 (1987-04-01), Usher
patent: 4668476 (1987-05-01), Bridgham et al.
patent: 4816513 (1989-03-01), Bridgham et al.
patent: 4877805 (1989-10-01), Kligman
patent: 4891227 (1990-01-01), Thaman et al.
patent: 4891228 (1990-01-01), Thaman et al.
patent: 4963656 (1990-10-01), Mitani
patent: 4983382 (1991-01-01), Wilmott et al.
patent: 5017691 (1991-05-01), Lee
patent: 5028695 (1991-07-01), Eckmayer et al.
patent: 5079003 (1992-01-01), Scaffidi
patent: 5122536 (1992-06-01), Perricone
patent: 5140043 (1992-08-01), Darr et al.
patent: 5223420 (1993-06-01), Rabaud et al.
patent: 5358934 (1994-10-01), Borovsky et al.
patent: 5449661 (1995-09-01), Nakamura et al.
patent: 5503825 (1996-04-01), Lane
patent: 5523291 (1996-06-01), Janzen et al.
patent: 5587396 (1996-12-01), Smith
patent: 5643949 (1997-07-01), Van Scott et al.
patent: 5648209 (1997-07-01), Avrameas et al.
patent: 5726040 (1998-03-01), Ensley et al.
patent: 5736537 (1998-04-01), Gubernick et al.
patent: 5770697 (1998-06-01), Ferrari et al.
patent: 5776441 (1998-07-01), Scancarella et al.
patent: 5801192 (1998-09-01), Dumas et al.
patent: 5945409 (1999-08-01), Crandall
patent: 5948418 (1999-09-01), Maes et al.
patent: 6025347 (2000-02-01), Gubernick et al.
patent: 08/225.594 (1993-03-01), None
patent: 08225594 (1993-09-01), None
patent: WO 94/08588 (1994-04-01), None
patent: WO 96/35428 (1996-11-01), None
Atlas of protein sequence and structure, vol. 5, 1972, p. 96.
Database Caplus, DN 113:1980321. WO 8909787 ; Registry No. 129393-50-6.
Heiber, A.D. et al., Detection of Elastin in the Human Fetal Membranes: Proposed Molecular Basis for Elasticity; Placenta; vol. 18; pp. 301-312; 1997.
Gibson, M.A. et al., Further Characterization o fProteins Associated with Elastic Fibre Microfibrils Including the Molecular Cloning of MAGP-2 (MP25); The Journal of Biological Chemistry; vol. 271, No. 2, pp. 1096-1103; Jan. 12, 1996.
Price, L.S.C. et al., Valyl-Alanyl-Prolyl-Glycine (VAPG) Sreves as a Quantatative Marker for Human Elastins; Matrix; vol. 13 pp. 307-311; 1993.
Blankenship, J.W. et al., Oxysterol Incorporation Into Rat Aorta Resulting in Elastin Compositional Changes; Lipids; vol. 26, No. 5; pp. 381-384; 1991.
Sandberg, L.B. et al., Quantitation of Elastin in Tissues and Culture: Problems Related to the Accurate Measurement of Small Amounts of Elastin With Special Emphasis on the Rat; Connective Tissue Research; vol. 25, pp. 139-148; 1990.
Sandberg, L.B. et al., Structural Guidelines for an Acceptable Elastin an Tropoelastin: Application Towards Quantitation of Elastin Accumulation in Tissue Culture; Elastin: Chemical and Biological Aspects (Reprinted); pp. 22-24; 1009.
Sandberg, L.B. et al., Quantitation of Elastin Through Measurement of Its Pentapeptide Content; Biochemical and Biophysical Research Communications; vol. 136, No. 2 pp. 672-678; Apr. 29, 1986.
Database CaPlus, AN 108:167920. Bayer et al. Z. Naturforsch., C: Biosci, 42(4), 455-60), Apr. 1987.
Hunninghake et al. Science, 212, 925-927, May 1981.
Database Caplus, DN 127:219499. Morrelli et al. J. Pept. Res., 49(6), 429-449, Jun. 1997.
Database Caplus, DN 122:102414. Bisaccia et al. Int, J. Pept. Res, 44, 332-341, Apr. 1994.
Database Caplus, AN 115:65185, Doi, R. et al., Effects of synthetic human pancreastatin on pancreatic secretion an dblood flow in rats and dogs. Peptides. 1991, vol. 12(3), pp. 449-502.
Database Caplus, AN 107:54378, Raju, K. et al., Primary structure of bovine elastin a, b, and c deduced from the sequences of cDNA clones. J. Biol. Chem., 1987, 262(12), pp. 5755-5762.
Database Capuls, AN 107:191131, Charten et al. QSAR for peptide bioactivities. Further studies. Pharmacochem. Libr. 1987, vol. 10, pp. 285-290.
Database Capuls, 129:187343, Lograno, M. et al., Identification of elastin peptides with vasorelaxant activity on rat thoracic aorta. Int. J. Biochem. Cell Biol., 1998, vol. 30 pp. 497-503.
Ferrance, J., Examiner's first report on patent application no. 30854/99 by Connective Tissue Imagineering LLC, 2001.

Affiliated with

Also associated with

Rating

Elastin peptide analogs and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Elastin peptide analogs and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Elastin peptide analogs and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3497928